MetLife (NYSE:MET) Given New $88.00 Price Target at JPMorgan Chase & Co.

MetLife (NYSE:MET) had its price target lifted by equities researchers at JPMorgan Chase & Co. from $86.00 to $88.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 6.14% from the company’s previous close.

MET has been the topic of several other research reports. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Barclays lifted their price target on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Jefferies Financial Group lifted their target price on MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Finally, Piper Sandler raised their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $90.00.

MetLife Price Performance

MET opened at $82.91 on Tuesday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The business has a fifty day moving average of $82.85 and a 200 day moving average of $78.84. MetLife has a 52-week low of $64.61 and a 52-week high of $89.05. The stock has a market cap of $57.41 billion, a P/E ratio of 16.72, a PEG ratio of 0.76 and a beta of 1.07.

Institutional Trading of MetLife

Institutional investors have recently made changes to their positions in the business. MeadowBrook Investment Advisors LLC raised its stake in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after buying an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new position in MetLife during the 3rd quarter valued at approximately $30,000. Finally, Fortitude Family Office LLC raised its holdings in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after buying an additional 266 shares during the last quarter. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.